Patient Care Management Strategies for Severe Heart Failure in Rhône-Alpes, France.
NCT ID: NCT02763670
Last Updated: 2018-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
186 participants
INTERVENTIONAL
2015-09-30
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to investigate the management strategies for patients with chronic heart failure stage III or IV NYHA, and heart failure patients with stage II NYHA with previous hospitalization for heart failure.
This is a longitudinal observational multicenter study comparing a management strategy including patient education and monitoring as part of a hospital dedicated organization and an organization of care as usually done in France.
The primary endpoint was a composite endpoint of morbidity and mortality involving deaths, unplanned readmissions and emergency visits for heart failure.
The expected number of patients is 720 patients (360 per strategy). The follow-up duration of 24 months.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a Back-to-home Support Program for Hospitalized Patients for Heart Failure
NCT05566145
Evaluation of the Program to Help Return Home Patients Hospitalized for Heart Failure, From Paris Saint-Joseph Hospital
NCT04613973
Evaluation and Support Care Process Within the Care Pathway of Heart Failure Patients
NCT04878263
Optimizing Treatments for Heart Failure During Hospitalization
NCT05910437
Development of a Predictive Algorithm for the Risk of Rehospitalization of Patients With Heart Failure
NCT03905226
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interventional
PRETICARD patient care management
PRETICARD patient care management
A standardized and specialized network to take care of the severe cardiac insufficiency:
* An initial assessment and consultations with health professionals specialized in severe cardiac insufficiency during the hospitalization for cardiac insufficiency
* At 1 months, consultations and acts realized by health professionals specialized (one hospital day care)
* At 2 months, a therapeutic education program for heart failure patients, approved by the Rhône-Alpes regional public health authorities (week hospital: two days and one night).
* At 6 and 18 months, one cardiology consultation
* At 12 and 24 months, consultations and acts realized by health professionals specialized (one hospital day care)
Control
Heterogenous "as usual" patient care management.
"As usual " patient care management
Conventional management of heart failure patients is defined in the guide HAS ("Haute Autorité de Santé") care course. Patient follow-up, however, is defined by the patient's physician and / or cardiologist at the waning of his hospitalization, according to the usual practice for patients with stage II, III or IV NYHA.
According to these recommendations, the patient should see his cardiologist at least once a year.
Usual practices are:
* An initial assessment and consultations with health professionals specialized in severe cardiac insufficiency during the hospitalization for cardiac insufficiency
* At 12 months, a cardiologic consultation. For the study, three evaluation points are programmed: two by phone at 6 and 18 months, two by a consultation at 24 months. This interview aimed to evaluate the number of hospitalization, consultations and acts realized by health professionals specialized (the information in the logbook).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PRETICARD patient care management
A standardized and specialized network to take care of the severe cardiac insufficiency:
* An initial assessment and consultations with health professionals specialized in severe cardiac insufficiency during the hospitalization for cardiac insufficiency
* At 1 months, consultations and acts realized by health professionals specialized (one hospital day care)
* At 2 months, a therapeutic education program for heart failure patients, approved by the Rhône-Alpes regional public health authorities (week hospital: two days and one night).
* At 6 and 18 months, one cardiology consultation
* At 12 and 24 months, consultations and acts realized by health professionals specialized (one hospital day care)
"As usual " patient care management
Conventional management of heart failure patients is defined in the guide HAS ("Haute Autorité de Santé") care course. Patient follow-up, however, is defined by the patient's physician and / or cardiologist at the waning of his hospitalization, according to the usual practice for patients with stage II, III or IV NYHA.
According to these recommendations, the patient should see his cardiologist at least once a year.
Usual practices are:
* An initial assessment and consultations with health professionals specialized in severe cardiac insufficiency during the hospitalization for cardiac insufficiency
* At 12 months, a cardiologic consultation. For the study, three evaluation points are programmed: two by phone at 6 and 18 months, two by a consultation at 24 months. This interview aimed to evaluate the number of hospitalization, consultations and acts realized by health professionals specialized (the information in the logbook).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Heart failure stage III or IV NYHA, or heart failure patients with stage II NYHA with previous hospitalization for heart failure.
* Patient who has received a written or oral information of the study
* Patient affiliated with French health Insurance
Exclusion Criteria
* Progressive neoplastic pathology.
* Patient with impaired cognitive functions known.
* Patient subject to a measure of socio-legal protection.
* Heart failure secondary to curable causes (an arrhythmia, valvular dysfunction, myocardial infarction, bypass surgery scheduled, aortic stenosis, breaking rope…)
* Dyspnea pulmonary origin: pulmonary arterial hypertension pre-capillary origin catheterization, defined by a Pcap ≤15 mmHg.
* Patient who underwent ventricular mechanical assistance.
* Patient with acute breathlessness is explained by: a severe lung infection (CPT \<60% of predicted, ventricular ejection fraction \<60% predicted) or pulmonary embolism or respiratory failure with ambient air PaO2 (arterial oxygen pressure) below 60 mmHg or oxygen therapy.
* Dialysis patient
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospices Civils de Lyon
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013.838
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.